SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-19-000015
Filing Date
2019-10-29
Accepted
2019-10-29 12:58:24
Documents
95
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-30sep19x10q.htm   iXBRL 10-Q 2762384
2 EXHIBIT 10.1 exhibit101-30sep19x10q.htm EX-10.1 21737
3 EXHIBIT 31.1 exhibit311-30sep19x10q.htm EX-31.1 11020
4 EXHIBIT 31.2 exhibit312-30sep19x10q.htm EX-31.2 11664
5 EXHIBIT 32.1 exhibit321-30sep19x10q.htm EX-32.1 6682
  Complete submission text file 0001048477-19-000015.txt   12358362

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20190930_pre.xml EX-101.PRE 534980
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20190930.xsd EX-101.SCH 70086
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20190930_def.xml EX-101.DEF 349963
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20190930_cal.xml EX-101.CAL 118618
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20190930_lab.xml EX-101.LAB 871437
82 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-30sep19x10q_htm.xml XML 2841687
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 191175663
SIC: 2834 Pharmaceutical Preparations